It’s a blow for GSK, which hopes that Trelegy (fluticasone furoate+umeclidinium+vilanterol) will help to revive the fortunes of its respiratory diseases franchise. The company had been propped ...

GSK’s new asthma drug Relvar Ellipta has shown itself to be superior to existing treatments in a major real world trial, the Salford Lung Study (SLS). Developed with US respiratory specialist ...

New York State Teachers Retirement System lowered its stake in shares of Innoviva, Inc. (NASDAQ:INVA – Free Report) by 2.4% ...

A NEW multicenter study, TOReTO, has shown that dual bronchodilator therapy can help reduce exacerbations in patients with chronic obstructive pulmonary disease (COPD), with notable differences in ...

It is a combination of an inhaled corticosteroid called fluticasone furoate, a long-acting muscarinic antagonist called umeclidinium, and a long-acting beta2-adrenergic agonist called vilanterol. The ...

Because acid reflux can cause bronchoconstriction, NIH asthma guidelines state the following: "For patients who have poorly controlled asthma ... investigation for GERD [gastroesophageal reflux ...

The Spanish COPD guidelines recommend treatment of the mixed COPD–asthma phenotype with ICS and a long-acting bronchodilator (LABD) as a first option to improve lung function, respiratory ...

Breaking the Cycle: The Importance of Early Intervention in Hidradenitis Suppurativa ...

Asthma inhalers are hand-held devices that allow you to inhale a dose of medication to treat asthma symptoms. There are many types of asthma inhalers. They differ in whether they're used for quick ...